Table 3. Sources and antimicrobial activity of Pseudomonas geniculata from single hospital.
| No. | Collection year | Ward | Source | MIC (ug/mL) | ||||
|---|---|---|---|---|---|---|---|---|
| Tigecycline | Ceftazidime | TMP/SMX | Levofloxacin | TZP | ||||
| 14 | 2006 | ICU | Blood | 0.25 | 16 | 4 : 76 | 1 | 16 : 4 |
| 58 | 2008 | ICU | Blood | 4 | 16 | 64 : 1216 | 16 | 16 : 4 |
| 71 | 2009 | ICU | Blood | 4 | 32 | 16 : 304 | 1 | 16 : 4 |
| 73 | 2009 | GW | Blood | 0.5 | 8 | 0.25 : 4.75 | 1 | 4 : 4 |
| 102 | 2008 | ICU | Sputum | 8 | >64 | 64 : 1216 | 16 | 64 : 4 |
| 106 | 2010 | GW | Pus | 2 | >64 | 4 : 76 | 2 | > 256 : 4 |
| 113 | 2011 | GW | Blood | 1 | 4 | 32 : 608 | 2 | 8 : 4 |
| 115 | 2011 | GW | Sputum | 4 | >64 | 16 : 304 | 4 | > 256 : 4 |
| 119 | 2011 | ICU | Blood | 16 | >64 | 16 : 304 | 32 | > 256 : 4 |
| 122 | 2011 | ICU | Blood | 16 | >64 | 32 : 608 | 64 | 256 : 4 |
MIC, minimum inhibitory concentration; TMP/SMX, trimethoprim-sulfamethoxazole; TZP, piperacillin/tazobactam; ICU, intensive care unit; GW, general ward.